Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ

Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) are considering a merger the Wall Street Journal reported late Wednesday, citing people familiar with the matter.

Pfizer has approached Allergan about a deal. Talks are said to be in the early stages and may not lead to a deal.

Allergan has a market cap of $113 billion versus $219 billion for Pfizer.

You May Also Be Interested In

• UWMC urges Two Harbors stockholders to reject CCM merger deal
• Gores Holdings XI prices $312M IPO on Nasdaq
• RedHill Biopharma closes $6M private placement with warrant upside